Terlipressin acetate is a synthetic analogue of vasopressin classified as a potent vasoactive agent primarily indicated for the treatment of severe hypotension and complications related to variceal hemorrhage.… Read more
Terlipressin acetate is a synthetic analogue of vasopressin classified as a potent vasoactive agent primarily indicated for the treatment of severe hypotension and complications related to variceal hemorrhage. By acting as a V1 receptor agonist, this compound induces vasoconstriction, effectively increasing systemic vascular resistance and blood pressure in critical care settings. The range of associated Terlipressin acetate reference standards includes the active pharmaceutical ingredient, pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds. These high-quality materials are essential for pharmaceutical laboratories conducting rigorous impurity profiling, method validation, and ongoing quality control. Utilizing these specific standards allows analytical chemists to ensure accurate quantification and identification during routine stability testing and regulatory compliance procedures, supporting the development and monitoring of therapeutic drug formulations.